|
Table of Contents Introduction
Zollinger-Ellison Syndrome (Gastrinoma)
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Countries: Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Chemo Espana, S.A.
Clinical Trial Overview of Chemo Espana, S.A.
Novartis AG
Clinical Trial Overview of Novartis AG
Aspen Pharmacare Holdings Ltd
Clinical Trial Overview of Aspen Pharmacare Holdings Ltd
Bluefish Pharmaceuticals AB
Clinical Trial Overview of Bluefish Pharmaceuticals AB
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Eisai Co., Ltd.
Clinical Trial Overview of Eisai Co., Ltd.
Dr. Reddy's Laboratories Limited
Clinical Trial Overview of Dr. Reddy's Laboratories Limited
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Ardelyx, Inc.
Clinical Trial Overview of Ardelyx, Inc.
Clinical Trial Overview of Top Institutes / Government
The National Institute of Diabetes and Digestive and Kidney Diseases
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Academic and Community Cancer Research United
Clinical Trial Overview of Academic and Community Cancer Research United
Eastern Cooperative Oncology Group
Clinical Trial Overview of Eastern Cooperative Oncology Group
Medical Co. LTA Clinical Pharmacology Center
Clinical Trial Overview of Medical Co. LTA Clinical Pharmacology Center
Stanford University
Clinical Trial Overview of Stanford University
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Region, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Europe, Top Countries, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, North America, Top Countries, 2015*
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Phase, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aspen Pharmacare Holdings Ltd, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ardelyx, Inc., 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic and Community Cancer Research United, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Co. LTA Clinical Pharmacology Center, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2015*
List of Figures
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Region (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
GlobalData Methodology
|
현재위치 : 
